Eur Rev Med Pharmacol Sci 2023; 27 (2): 649-652
DOI: 10.26355/eurrev_202301_31066

Myasthenia gravis as an unusual non-hematological autoimmune manifestation of a relapsed chronic lymphocytic leukemia – clinical case and review of literature

S. Dimitrova, M. Efraim, I. Micheva

Department of Hematology, Medical University, UMHAT “Sveta Marina”, Varna, Bulgaria. stelladimitrova@abv.bg


BACKGROUND: Autoimmune phenomena are well known to complicate chronic lymphocytic leukemia (CLL) and occur in 10% to 25% of the cases. Although less common, non-hematological autoimmune manifestations have been reported. Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction, characterized by fatigable weakness of the extraocular, bulbar, and limb musculature. The co-existence of MG and CLL is exceedingly rare and there are very few cases reported in literature.

CASE PRESENTATION: We present a case of a 63-year-old female patient with a severe form of MG which is likely related to a relapse of CLL. Treatment with combined targeted and immunotherapy was initiated with acceptable tolerability.

CONCLUSIONS: Targeted agents and monoclonal antibodies exert complex activities on the patient’s immune system. It will be of interest to assess their role in managing autoimmune complications, accompanying CLL.

Free PDF Download

To cite this article

S. Dimitrova, M. Efraim, I. Micheva
Myasthenia gravis as an unusual non-hematological autoimmune manifestation of a relapsed chronic lymphocytic leukemia – clinical case and review of literature

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 2
Pages: 649-652
DOI: 10.26355/eurrev_202301_31066